Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$295,270
-$54,901 QoQ
Shares Held
35,532
+7.6% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#100
of 201 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. ARVN ranks #162 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $295,270 | 35,532 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $350,171 | 33,035 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $400,986 | 33,810 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $276,295 | 32,429 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $285,759 | 38,826 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $272,558 | 38,826 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $756,007 | 39,437 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $915,743 | 37,180 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $989,731 | 37,180 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,080,834 | 26,183 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,077,692 | 26,183 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $514,234 | 26,183 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $649,862 | 26,183 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $692,562 | 25,350 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $867,223 | 25,350 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $1,127,821 | 25,350 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $1,066,981 | 25,350 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $1,706,055 | 25,350 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $1,339,785 | 16,311 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $1,288,746 | 15,682 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $1,207,514 | 15,682 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $878,204 | 13,286 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $1,128,379 | 13,286 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $313,682 | 13,286 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $445,612 | 13,286 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $354,075 | 8,786 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||